Identification and characterization of in vitro and in vivo fidarestat metabolites: Toxicity and efficacy evaluation of metabolites

The progression of diabetic complications can be prevented by inhibition of aldose reductase and fidarestat considered to be highly potent. To date, metabolites of the fidarestat, toxicity, and efficacy are unknown. Therefore, the present study on characterization of hitherto unknown in vitro and in vivo metabolites of fidarestat using liquid chromatography–electrospray ionization tandem mass spectrometry (LC/ESI/MS/MS) is undertaken. In vitro and in vivo metabolites of fidarestat have been identified and characterized by using LC/ESI/MS/MS and accurate mass measurements. To identify in vivo metabolites, plasma, urine, and feces samples were collected after oral administration of fidarestat to Sprague–Dawley rats, whereas for in vitro metabolites, fidarestat was incubated in human S9 fraction, human liver microsomes, and rat liver microsomes. Furthermore, in silico toxicity and efficacy of the identified metabolites were evaluated. Eighteen metabolites have been identified. The main in vitro phase I metabolites of fidarestat are oxidative deamination, oxidative deamination and hydroxylation, reductive defluroniation, and trihydroxylation. Phase II metabolites are methylation, acetylation, glycosylation, cysteamination, and glucuronidation. Docking studies suggest that oxidative deaminated metabolite has better docking energy and conformation that keeps consensus with fidarestat whereas the rest of the metabolites do not give satisfactory results. Aldose reductase activity has been determined for oxidative deaminated metabolite (F‐1), and it shows an IC50 value of 0.44 μM. The major metabolite, oxidative deaminated, did not show any cytotoxicity in H9C2, HEK, HEPG2, and Panc1 cell lines. However, in silico toxicity, the predication result showed toxicity in skin irritation and ocular irritancy SEV/MOD versus MLD/NON (v5.1) model for fidarestat and its all metabolites. In drug discovery and development research, it is distinctly the case that the potential for pharmacologically active metabolites must be considered. Thus, the active metabolites of fidarestat may have an advantage as drug candidates as many drugs were initially observed as metabolites.     

Synthesis and characterization of potential impurities of Oxcarbazepine drug substance: An antiepileptic agent

Oxcarbazepine is a drug substance used to treat epilepsy. During its bulk synthesis of various impurities formation will be observed. Herein we describe the formation, synthesis and characterization of four potential impurities, namely, N-acetyl Oxcarbazepine, N-formyl Oxcarbazepine, N-carbamoyl Oxcarbazepine, and Oxcarbazepine dimer. These impurities are listed in several Pharmacopoeias and the control of these impurities below the threshold level is essential. Our study will be a guide for making these reference standards.     

Synthesis and structural studies of complexes of Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) with substituted chalcones

Complexes of Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) with 3-(2-pyridyl)-1-(2-hydroxy phenyl)-2-propen-1-one (PHPO), 3-(1-naphthyl)-1-(2-hydroxy phenyl)-2-propen-1-one (NHPO) and 3-(3,4-dimethoxy phenyl)-1-(2-hydroxy phenyl)-2-propen-1-one (DMPHPO) have been synthesized and characterized by analytical, conductivity, thermal, magnetic, infrared, electronic and electron spin resonance data. Based on analytical data the stoichiometry of the complexes has been found to be 1 : 2. The conductivity data show that all these complexes are non-electrolytes. The infrared spectral data indicate that the ligand PHPO acts as uninegative tridentately towards Co(II) and Ni(II) and bidentately with Cu(II), Zn(II) and Cd(II). Ligands like NHPO and DMPHPO act as uninegative bidentately with all the metal ions. The electronic spectral data suggest that all the Co(II) complexes and Ni(II) of PHPO complex are octahedral and all the Cu(II) and Ni(II) of NHPO and DMPHPO complex are square-planar. The complex of Zn(II) and Cd(II) are tetrahedral. ESR parameters of Cu(II) complexes have been calculated and relevant conclusions have been drawn with respect to the nature of bonds present in them.     

In situ preparation of polymeric cobalt phthalocyanine–decorated TiO2 nanorods for efficient photocatalytic CO2 reduction

The integration of photosensitizers with low-cost and non-toxic metal oxides is a promising strategy to design heterogeneous photocatalysts for CO₂ reduction. Herein, p–n heterojunction photocatalysts (T-CoPPcs) consisting of p-type polymeric cobalt phthalocyanines (CoPPcs) as a photosensitizer coupled with n-type TiO₂ nanorods were fabricated through a facile, eco-friendly, one-pot hydrothermal reaction. In this process, CoPPcs were grown on n-type TiO₂ nanorods, whereas protonated titanate nanorods began converting to the highly crystalline anatase phase with small crystals on the TiO₂ surfaces. The introduction of CoPPcs not only improved the solar light utilization but also accelerated the separation and migration of charge carriers via the p–n heterojunction with the strong interfacial contact Ti–O–Co bond. The increases in crystallinity and surface area of TiO₂ nanorods also contributed to the enhanced photoactivities of T-CoPPcs. The CO₂ photoreduction of the synthesized materials was evaluated in CO₂-saturated MeCN/water using [Co(bpy)₃]²⁺ as a cocatalyst and triethanolamine as a hole scavenger. The optimized nanocomposite exhibited a remarkable CO generation rate of 4.42 mmol/h/g with a high selectivity of 85.3% and outstanding catalytic stability. The influences of cocatalyst concentration, water content, catalyst loading, and hole scavenger concentration were optimized for efficient CO₂ reduction. The photocatalytic CO₂ conversion efficiency of the present system is found to be higher than that of TiO₂-based materials reported in the literature. We believe that this research into a heterostructural design strategy and photocatalytic system may be an inspiration for the development of photocatalytic CO₂-to-CO conversion.     

An Improved Process for the Enantioselective Synthesis of HCV NS5A Inhibitor Elbasvir (MK-8742) Chiral Amine Intermediate

Russian Journal of General Chemistry - Large-scale enantioselective synthesis of the chiral amine unit of HCV NS5A inhibitor Elbasvir has been accomplished in six steps, with 55% overall yield. The...     

Solid-State Isolation of Cyclic Alkyl(Amino) Carbene (cAAC)-Supported Structurally Diverse Alkali Metal-Phosphinidenides

Cyclic alkyl(amino) carbene (cAAC)-supported, structurally diverse alkali metal-phosphinidenides 2 – 5 of general formula ((cAAC)P-M)_n(THF)_x [ 2 : M=K, n=2, x=4; 3 : M=K, n=6, x=2; 4 : M=K, n=4, x=4; 5 : M=Na, n=3, x=1] have been synthesized by the reduction of cAAC-stabilized chloro-phosphinidene cAAC=P-Cl ( 1 ) utilizing metallic K or KC₈ and Na-naphthalenide as reducing agents. Complexes 2 – 5 have been structurally characterized in solid state by NMR studies and single crystal X-ray diffraction. The proposed mechanism for the electron transfer process has been well-supported by cyclic voltammetry (CV) studies and Density Functional Theory (DFT) calculations. The solid state oligomerization process has been observed to be largely dependent on the ionic radii of alkali metal ions, steric bulk of cAAC ligands and solvation/de-solvation/recombination of the dimeric unit [(cAAC)P-M(THF)_x]₂.     

A PASE-based approach towards 12-(1H-1,2,3-triazol-1-yl)-indolo[2,1-a]isoquinolines via the reaction of 3-(isoquinolin-1-yl)-1,2,4-triazines with benzyne

1. Download : Download high-res image (63KB)
2. Download : Download full-size image

     

Indium trichloride: a useful catalyst for ionic Diels–Alder reactions

Indium trichloride (20 mol%) in nitromethane permits ionic Diels–Alder reaction of a variety of 2,3-olefinic acetals to form the corresponding cycloadducts in good yields with good endo selectivities.